478 what kind of direct oral anticoagulant presents the lowest bleeding risk after endoscopic resection of colorectal polyps?

Direct oral anticoagulants (DOACs), including dabigatran, rivaroxaban, apixaban, and edoxaban, have become popular as equivalent to warfarin for stroke prevention in non-valvular atrial fibrillation; however, bleeding risk from DOACs, especially the difference in risks among DOACs in endoscopic treatment, has not been reported. The study aimed to evaluate delayed bleeding risk related to early resumption of DOACs and compare the bleeding risk among DOACs after endoscopic resection of colorectal polyps.

Source: Gastrointestinal Endoscopy - May 31, 2019 Category: Gastroenterology Authors: Kazuko Beppu, Kazunori Yokoi, Hisafumi Yamagata, Satoko Suzuki, Tatsuo Ogihara Tags: Oral abstract Source Type: research